Luminex Corporation (NASDAQ:LMNX), a developer of biological testing technologies, recently reported that its new xTAG Gastrointestinal Pathogen Panel (“GPP”) test has been successfully used at German hospital, Kliniken der Stadt Koln, as a first-line screen for patients suspected of having the Escherichia coli (E. coli) infection. The E. coli is a common bacterium that lives [...]